<DOC>
	<DOCNO>NCT01019447</DOCNO>
	<brief_summary>To compare conventional polyglactin 910 suture triclosan-coated polyglactin 910 antimicrobial suture reduction surgical site infection associate health economic benefit .</brief_summary>
	<brief_title>The Impact Using Triclosan-antibacterial Sutures Incidence Surgical Site Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<mesh_term>Triclosan</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>All patient different age Gender Risk factor procedure candidate surgical intervention period study Patients establish preoperative infection operative site</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Surgical site infection</keyword>
	<keyword>Antimicrobial triclosan-coated polyglactin 910 suture</keyword>
	<keyword>Length hospital stay</keyword>
	<keyword>SSI</keyword>
</DOC>